🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Visit Nigel Hircock and Dan Walsh at the Bridge to Life stand during #EAHPBA2025 in Dublin to discuss the findings from Rio Hortega University Hospital's implementation of HOPE in liver transplantation. #HOPE #LiverTransplantation #OrganTransplantation

⭐️ HOPE for the Week: One of 9 abstracts accepted at #ILTS2025! Italy’s Gemelli IRCCS found HOPE improves graft preservation—especially in donors under 65. 🔗 Read more: ow.ly/EieI50W50tg 🧠 More abstracts: ow.ly/7C2X50W50tf

⭐️ HOPE for the Week: Our 2nd ILTS 2025 abstract highlights HOPE in a middle-volume center (40–45 LTs/year). 🧬 Used in 39 cases ✅ Better kidney function 🏥 Shorter hospital stay 📉 Lower rejection in MELD >25 See more of our abstracts: ow.ly/Tm7B50WaWsa #HOPE #ILTS2025

Bridge to Life will be exhibiting at the AOPO Annual Meeting next week! Join us in Denver from June 22-24 and visit us at Booth #117. We look forward to connecting with you—see you there! #AOPOAM25 #BridgeToLife #OPO #OrganProcurement

We had a great time connecting at the 2025 TTS Annual Scientific Meeting in Austin, TX! 🌟 We're proud to support this impactful event as a sponsor, and we appreciate everyone who stopped by our booth. Let’s keep advancing the standard of transplant care—together. #TTS2025

Read the full press release: bridgetolife.com/bridge-to-life… Exciting update from BTL: The FDA has granted 510(k) Clearance for EasiSlush® for use to induce regional hypothermia in certain surgical procedures such as open heart and kidney procedure. This expanded indication reflects our

👏 Thank you to everyone who joined us yesterday at #AOPO2025 for our session: “Perfuse It or Lose It? The Debate Over Machine Preservation” 💡Special thanks to our speakers for sparking powerful dialogue on machine perfusion. #AOPO2025 #OrganPreservation #BridgeToLife

⭐️ HOPE for the Week: In one abstract accepted to #ILTS2025, HOPE preserved grafts for 3 complex recipients—a 4-month-old infant, a 2-year-old w/ cancer, & a 38-year-old in acute liver failure. All had smooth recoveries & strong graft function. Read more: ow.ly/ASF250WaXoA

Fresh look, same mission. BTL’s CEO, Don Webber recaps #ILTS2025 & previews what’s ahead at #WTC2025—incl. new data on HOPE’s clinical impact. Dive into our latest CEO Perspective. bridgetolife.com/ceo-don-webber… #BridgeToLife #Transplantation #MachinePerfusion #OrganPreservation

Last week, the Bridge to Life team took part in the Pediatric Hepato-Biliary Surgery and Transplantation Scientific Meeting at Hôpital Necker in Paris. The event brought together leading international experts to explore and share the latest advancements.

Bridge to Life is proud to be at #ESOT2025 in London this week! 🌍 Stop by Booth B22 to learn how we're advancing organ preservation with innovative, proven solutions that support transplant teams around the world. Let’s connect! 👋 #ESOTcongress

Bridge to Life was proud to sponsor the 1st Annual DDI Golf Outing to support Sam, a wife and mom battling advanced cancer. Big thanks to Dr. @chasewehrle and all who helped make a difference for the Gauriloff family. 💚 #DDIGolfOuting #BridgeToLife #ClevelandClinic

Bridge to Life led an advanced #ESOTCongress Machine Perfusion Immersive session—giving surgeons + perfusionists hands-on experience with the VitaSmart™ system. Not just theory. Real assembly. Real perfusion. Pushing perfusion forward. #VitaSmart #MachinePerfusion

⭐️ HOPE for the Week: Our 4th #ILTS2025 abstract highlights how HOPE helped 12 pediatric liver transplants—no graft dysfunction, fast recovery, no re-transplants. A promising tool for tough cases. Read the full abstract: ow.ly/6ZbI50WaXgp #HOPE #PediatricTransplant

Bridge to Life Mid-Year International Team Meeting: ✅ Reflection: We reviewed the milestones we've achieved over the past 6 months 📈 Planning: With a renewed sense of purpose we’re charting the path for the rest of 2025 & beyond 🚀 The 2nd half of the year is full of potential

⭐️ HOPE for the Week: Our 5th #ILTS2025 abstract explores HOPE’s impact on HCC recurrence after transplant. In 76 patients, HOPE use lowered recurrence—even with older donors—and reduced IRI and CIT. Read the full abstract: ow.ly/yfl850WaXsa #HCC #LiverTransplantation

Bridge to Life is unveiling pivotal 12-month data on HOPE at #WTC2025! From plenary sessions to late-breaking abstracts, see how we’re shaping the future of liver transplant.🌍🫀 📖 Full press release: bridgetolife.com/bridge-to-life… #Transplantation #BridgeToLife #HOPE

⭐️ HOPE for the Week: We’re pleased to spotlight our 6th abstract accepted at ILTS 2025. For patients with acute liver failure (ALF) or acute-on-chronic liver failure (ACLF)—conditions known for high short-term mortality—transplant timing is critical. A recent 4-year review

⭐️ HOPE for the Week: Highlighting one of nine accepted ILTS 2025 abstracts, this observational study assessed 26 liver transplants using HOPE VitaSmart™ over 2 years at a tertiary hospital in Castilla y León, Spain. Reported findings: • No cases of primary graft dysfunction

This past Monday, Bridge to Life was proud to sponsor and attend the 2025 TADS Capstone Celebration! Hosted by the Transplantation and Donation Sciences (TADS) program, the event brought together an inspiring community of students, donors, recipients, and advocates—all united by